Stock LLM Wiki

報告_MS_上銀2049_20260907

更新 2026-09-09

PDF 原檔:報告_MS_上銀2049_20260907_original.pdf

原始內容

M September 7, 2026 03:48 PM GMT

Hiwin Technologies Corp. | Asia Pacific

August Sales +1% MoM/+42% YoY

In this report, we focus on Hiwin's monthly sales, which we believe could be a catalyst for its share price.

Details:

  • August sales were NT$2,708mn (+1% MoM/+42% YoY).
  • QTD revenue was 67% of our 3Q26 estimate, at NT$7,996mn (+6% QoQ/ +33% YoY), and 68% of consensus, at NT$7,884mn (+5% QoQ/+32% YoY).

Our view:

  • We think 3Q26 is tracking slightly ahead of expectations.
  • Looking into 2H26, we maintain the view that Hiwin should continue to see revenue growth amid the industry recovery and margin expansions driven by higher utilization/price hikes.
  • We stay constructive on the stock, with current valuation at 29x 2027e P/E vs. a peak cycle level of 35-40x.

Exhibit 1 : Hiwin's monthly sales YoY vs. its share price since 2015

Source: Past performance is no guarantee of future results. Results shown do not include transaction costs. Source: Company data, TEJ, Morgan Stanley Research.

Morgan Stanley Taiwan Limited+

Derrick Yang Equity Analyst Derrick.Yang@morganstanley.com +886 2 2730-2862
Vivi Huang Research Associate Vivi.Huang@morganstanley.com +886 2 2730-2860
Andy Meng, CFA Equity Analyst Andy.Meng@morganstanley.com +852 2239-7689

Hiwin Technologies Corp. (2049.TW, 2049 TT)

Greater China Technology Hardware | Taiwan

Stock Rating Overweight
Industry View In-Line
Price target NT$450.00
Up/downside to price target (%) 23
Shr price, close (Sep 7, 2026) NT$364.50
52-Week Range NT$426.00-180.50
Sh out, dil, curr (mn) 354
Mkt cap, curr (mn) US$4,078
EV, curr (mn) US$4,067
Avg daily trading value (mn) US$45
Fiscal Year Ending 12/25 12/26e 12/27e 12/28e
EPS (NT$)** 4.31 9.77 11.77 13.77
Prior EPS (NT$)** - - - -
Revenue, net (NT$ mn) 24,263 29,992 34,688 39,123
EBITDA (NT$ mn) 4,001 6,485 7,488 8,431
ModelWare net inc (NT 1,526 3,457 4,165 4,873
$ mn)
P/E 45.0 37.3 31.0 26.5
P/BV 1.4 2.4 2.2 2.0
RNOA (%) 3.6 8.7 11.1 12.7
ROE (%) 4.1 9.2 10.4 11.2
EV/EBITDA 12.6 19.3 16.4 14.3
Div yld (%) 1.2 0.5 0.9 1.1
FCF yld ratio (%)** 2.0 3.4 2.4 2.7

Unless otherwise noted, all metrics are based on Morgan Stanley ModelWare framework

** = Based on consensus methodology

e = Morgan Stanley Research estimates

Morgan Stanley does and seeks to do business with companies covered in Morgan Stanley Research. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of Morgan Stanley Research. Investors should consider Morgan Stanley Research as only a single factor in making their investment decision.